The Implementation of PREP2 Algorithm Into Clinical Practice (PRESTO)

September 30, 2025 updated by: Sofia Straudi, University Hospital of Ferrara

The Implementation of PREP2 Algorithms Into Clinical Practice: a Strategy for Improving Rehabilitation Efficiency and Clinical Outcomes After Stroke. A Single-site Randomized Control Trial

Stroke is a worldwide major cause of disability with great social and economic burdens. The recovery of motor function is crucial for the patient to regain independence and quality of life. Identifying early predictors of motor recovery and outcomes is useful for planning personalized rehabilitation programs and increasing their efficiency. However, making predictions using a single clinical assessment is often difficult and a combination of multiple tools is required. In the last decades, were validated two predictive algorithms for upper limb function and independent walking that can be easily implemented into clinical practice with the aim of increasing knowledge on expected outcome after stroke in patients, families and rehabilitation teams. This will be the first single-site randomized control trial that will test the implementation of such tools in a rehabilitation setting in Italy.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Emilia-Romagna
      • Ferrara, Emilia-Romagna, Italy, 44124
        • Department of Neuroscience and Rehabilitation, University Hospital of Ferrara

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 76 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • diagnosis of stroke;
  • new upper and/or lower limb weakness.

Exclusion Criteria:

  • cerebellar or bilateral stroke;
  • contraindication to TMS;
  • cognitive or communication impairment precluding informed consent;
  • assisted walking prior to admission;
  • severe medical conditions.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Implementation Group
Predictions will be provided to the rehabilitation team and discussed with the patient and their family. Patients will receive a multidisciplinary rehabilitation according to their individual needs.
A) PREP2. It combines clinical measures and neurological biomarkers in the initial days after stroke: 1) SAFE score (day 3), which is the sum of shoulder abduction and finger extension strength in the paretic upper limb using the Medical Research Council (MRC); 2) NIH Stroke Scale (day 3); 3) transcranial magnetic stimulation (day 3-7) to determine the presence of MEPs in the paretic arm. According with the aforementioned measures, 4 categories of upper limb recovery will be identified: EXCELLENT, GOOD, LIMITED and POOR.
No Intervention: Control Group
This group will not received any information on the PREP2

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rehabilitation LOS (days)
Time Frame: Hospital discharge (an average of 3-6 months)
Length of stay as measure of rehabilitation efficiency
Hospital discharge (an average of 3-6 months)
Change in Functional International Measure between two time points
Time Frame: Baseline, hospital discharge (an average of 3-6 months)
Measure of efficiency of rehabilitation. Assess a patient's level of disability as well as change in patient status in response to rehabilitation.
Baseline, hospital discharge (an average of 3-6 months)
Change in Rehabilitation Complexity Scale between two time points
Time Frame: Baseline, hospital discharge (an average of 3-6 months)
Measure of the complexity of rehabilitation needs and/or interventions.
Baseline, hospital discharge (an average of 3-6 months)
Change in Rehabilitation strategies between two time points
Time Frame: Baseline, week 4
Will be assessed tracking: therapists confidence about patients' recovery (0-5 Likert scale); therapy content; therapy duration.
Baseline, week 4
Change in Action Research Arm Test between three time points
Time Frame: week 4, 12, week 26
To assess upper extremity performance (coordination, dexterity and functioning)
week 4, 12, week 26
Change in Fugl-Meyer Assessment between three time points
Time Frame: week 4, 12, week 26
To assess the sensorimotor impairment in individuals who have had stroke.
week 4, 12, week 26
Change in Stroke Impact Scale 3.0 between three time points
Time Frame: week 4, 12, week 26
To evaluate how stroke has impacted your health and life.
week 4, 12, week 26
Change in Electroencephalography power in beta band between three time points
Time Frame: week 4, week 12, week 26
EEG data will be recorded with the aim of characterizing the PREP2 recovery classes.
week 4, week 12, week 26
Change in Electroencephalography power in alpha band between three time points
Time Frame: week 4, week 12, week 26
EEG data will be recorded with the aim of characterizing the PREP2 recovery classes.
week 4, week 12, week 26
Change in Kinematic data recordings between three time points
Time Frame: week 4, week 12, week 26
Kinematic data of trunk and affected hand will be recorded during subject imitations. Kinematic data will be recorded with the aim of characterizing the PREP2 recovery classes.
week 4, week 12, week 26

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Applicability perception and satisfaction degree of the proposed intervention self-report questionnaire.
Time Frame: week 4
Self-report questionnaire using a Visual Analogue Scale (0 - Strongly disagree; 10 - Strongly agree). Higher score indicates greater satisfaction with the treatment.
week 4

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 27, 2019

Primary Completion (Actual)

December 20, 2022

Study Completion (Actual)

December 20, 2022

Study Registration Dates

First Submitted

October 29, 2020

First Submitted That Met QC Criteria

November 16, 2020

First Posted (Actual)

November 20, 2020

Study Record Updates

Last Update Posted (Estimated)

October 6, 2025

Last Update Submitted That Met QC Criteria

September 30, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on PREP2 algorithm

Subscribe